CellCentric
Latest round
- —
Last raised
- Nov 2026
Total raised
- $567M
Investors
- 17
About CellCentric
CellCentric Ltd, based in the UK, is focused on developing innovative pharmaceutical therapies, particularly targeting cancer treatment through advanced molecular inhibitors. Founded in 2003 and headquartered in Cambridge, UK, CellCentric Ltd concentrates on the development of pharmaceutical therapies, specifically their lead product, inobrodib. The company was co-founded by Azim Surani, with Will West serving as CEO., and RA Capital Management. CellCentric specializes in innovative pharmaceutical therapies, with its core product, inobrodib, a first-in-class small molecule inhibitor. This drug selectively targets the p300/CBP proteins to disrupt cancer cell growth, particularly in treating multiple myeloma. Inobrodib is undergoing clinical trials and is designed for oral administration, aiming to ease the treatment process for patients. Their clientele consists mainly of healthcare providers and oncology specialists across North America, Europe, and parts of Asia, who are seeking new cancer therapy options. CellCentric's revenue model involves partnerships with research institutions and pharmaceutical companies for the development and commercialization of inobrodib. The revenue anticipated from licensing agreements and future sales hinges on the regulatory approval and market entry of inobrodib.
Who invested in CellCentric
17 investors across 5 rounds
See all investors in CellCentric
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CellCentric
Who invested in CellCentric?
CellCentric has 17 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CellCentric raised?
CellCentric has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
What does CellCentric do?
CellCentric Ltd, based in the UK, is focused on developing innovative pharmaceutical therapies, particularly targeting cancer treatment through advanced molecular inhibitors.
Where is CellCentric headquartered?
CellCentric is headquartered in Cambridge, UK.
Which VCs invest in companies like CellCentric?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at CellCentric's stage. Their profiles are linked below.
VCs backing biotechnology startups
Raising like CellCentric? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.